The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Bio Pharma Buffer-Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2030
Synopsis
A buffer solution is comprised of a weak conjugate acid-base pair, for example, a weak acid and its conjugate base, or a weak base and its conjugate acid. Small quantities of other acids or bases are neutralized when added to the solution, and as a result, the solution resists changes in pH. Solutions with stable pH are required for the processing of protein-based biologic APIs because of their sensitivity to changes in pH. The stable pH range and capacity (the amount of acid/base that can be added without a change in pH) of a buffer are determined by the conjugate acid-base pair.
Most purification steps for downstream processing of biologics require buffers to equilibrate, condition, wash, elute, or concentrate the product. They are used in product isolation and purification steps to facilitate protein capture and polishing and also in the filtration process for the removal of viruses or depyrogenation. Aqueous solutions are also required for cleaning and disinfecting downstream processing equipment, such as chromatography matrices and membrane filtration systems. The main equipment involved in downstream processing with buffers includes mixers for buffer preparation, as well as equipment for purification, including packed-bed chromatography systems, fluidized beds, ultrafiltration and diafiltration membranes, microfiltration membranes, depth filtration cartridges, and virus-removal systems.
The global market for Bio Pharma Buffer was estimated to be worth US$ 841.4 million in 2023 and is forecast to a readjusted size of US$ 1376.7 million by 2030 with a CAGR of 7.2% during the forecast period 2024-2030
The key players are Avantor, Alfa Aesar (Thermo Fisher), Merck, Lonza, Bio-Rad, BD, GE, Healthcare, Promega Corporation, Hamilton Company, XZL BIO-TECHNOLOGY, SRL and so on. According to the revenue of these companies, we can know that the Bio Pharma Buffer industry is relative concentrated. Because the top 6 companies have more than 70% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bio Pharma Buffer, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Bio Pharma Buffer by region & country, by Type, and by Application.
The Bio Pharma Buffer market size, estimations, and forecasts are provided in terms of sales volume (K Liter) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bio Pharma Buffer.
Market Segmentation
By Company
Avantor
Alfa Aesar (Thermo Fisher)
Merck
Lonza
Bio-Rad
BD
GE Healthcare
Promega Corporation
Hamilton Company
XZL BIO-TECHNOLOGY
SRL
Segment by Type:
Phosphates Type
Acetates Type
TRIS Type
Others
Segment by Application
Research Institution
Pharmaceutical Industry
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Bio Pharma Buffer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Bio Pharma Buffer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Bio Pharma Buffer in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
A buffer solution is comprised of a weak conjugate acid-base pair, for example, a weak acid and its conjugate base, or a weak base and its conjugate acid. Small quantities of other acids or bases are neutralized when added to the solution, and as a result, the solution resists changes in pH. Solutions with stable pH are required for the processing of protein-based biologic APIs because of their sensitivity to changes in pH. The stable pH range and capacity (the amount of acid/base that can be added without a change in pH) of a buffer are determined by the conjugate acid-base pair.
Most purification steps for downstream processing of biologics require buffers to equilibrate, condition, wash, elute, or concentrate the product. They are used in product isolation and purification steps to facilitate protein capture and polishing and also in the filtration process for the removal of viruses or depyrogenation. Aqueous solutions are also required for cleaning and disinfecting downstream processing equipment, such as chromatography matrices and membrane filtration systems. The main equipment involved in downstream processing with buffers includes mixers for buffer preparation, as well as equipment for purification, including packed-bed chromatography systems, fluidized beds, ultrafiltration and diafiltration membranes, microfiltration membranes, depth filtration cartridges, and virus-removal systems.
The global market for Bio Pharma Buffer was estimated to be worth US$ 841.4 million in 2023 and is forecast to a readjusted size of US$ 1376.7 million by 2030 with a CAGR of 7.2% during the forecast period 2024-2030
The key players are Avantor, Alfa Aesar (Thermo Fisher), Merck, Lonza, Bio-Rad, BD, GE, Healthcare, Promega Corporation, Hamilton Company, XZL BIO-TECHNOLOGY, SRL and so on. According to the revenue of these companies, we can know that the Bio Pharma Buffer industry is relative concentrated. Because the top 6 companies have more than 70% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bio Pharma Buffer, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Bio Pharma Buffer by region & country, by Type, and by Application.
The Bio Pharma Buffer market size, estimations, and forecasts are provided in terms of sales volume (K Liter) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bio Pharma Buffer.
Market Segmentation
By Company
Avantor
Alfa Aesar (Thermo Fisher)
Merck
Lonza
Bio-Rad
BD
GE Healthcare
Promega Corporation
Hamilton Company
XZL BIO-TECHNOLOGY
SRL
Segment by Type:
Phosphates Type
Acetates Type
TRIS Type
Others
Segment by Application
Research Institution
Pharmaceutical Industry
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Bio Pharma Buffer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Bio Pharma Buffer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Bio Pharma Buffer in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Index1 Market Overview
1.1 Bio Pharma Buffer Product Introduction
1.2 Global Bio Pharma Buffer Market Size Forecast
1.2.1 Global Bio Pharma Buffer Sales Value (2019-2030)
1.2.2 Global Bio Pharma Buffer Sales Volume (2019-2030)
1.2.3 Global Bio Pharma Buffer Sales Price (2019-2030)
1.3 Bio Pharma Buffer Market Trends & Drivers
1.3.1 Bio Pharma Buffer Industry Trends
1.3.2 Bio Pharma Buffer Market Drivers & Opportunity
1.3.3 Bio Pharma Buffer Market Challenges
1.3.4 Bio Pharma Buffer Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Bio Pharma Buffer Players Revenue Ranking (2023)
2.2 Global Bio Pharma Buffer Revenue by Company (2019-2024)
2.3 Global Bio Pharma Buffer Players Sales Volume Ranking (2023)
2.4 Global Bio Pharma Buffer Sales Volume by Company Players (2019-2024)
2.5 Global Bio Pharma Buffer Average Price by Company (2019-2024)
2.6 Key Manufacturers Bio Pharma Buffer Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Bio Pharma Buffer Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Bio Pharma Buffer
2.9 Bio Pharma Buffer Market Competitive Analysis
2.9.1 Bio Pharma Buffer Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Bio Pharma Buffer Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bio Pharma Buffer as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Phosphates Type
3.1.2 Acetates Type
3.1.3 TRIS Type
3.1.4 Others
3.2 Global Bio Pharma Buffer Sales Value by Type
3.2.1 Global Bio Pharma Buffer Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Bio Pharma Buffer Sales Value, by Type (2019-2030)
3.2.3 Global Bio Pharma Buffer Sales Value, by Type (%) (2019-2030)
3.3 Global Bio Pharma Buffer Sales Volume by Type
3.3.1 Global Bio Pharma Buffer Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Bio Pharma Buffer Sales Volume, by Type (2019-2030)
3.3.3 Global Bio Pharma Buffer Sales Volume, by Type (%) (2019-2030)
3.4 Global Bio Pharma Buffer Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Research Institution
4.1.2 Pharmaceutical Industry
4.1.3 Others
4.2 Global Bio Pharma Buffer Sales Value by Application
4.2.1 Global Bio Pharma Buffer Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Bio Pharma Buffer Sales Value, by Application (2019-2030)
4.2.3 Global Bio Pharma Buffer Sales Value, by Application (%) (2019-2030)
4.3 Global Bio Pharma Buffer Sales Volume by Application
4.3.1 Global Bio Pharma Buffer Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Bio Pharma Buffer Sales Volume, by Application (2019-2030)
4.3.3 Global Bio Pharma Buffer Sales Volume, by Application (%) (2019-2030)
4.4 Global Bio Pharma Buffer Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Bio Pharma Buffer Sales Value by Region
5.1.1 Global Bio Pharma Buffer Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Bio Pharma Buffer Sales Value by Region (2019-2024)
5.1.3 Global Bio Pharma Buffer Sales Value by Region (2025-2030)
5.1.4 Global Bio Pharma Buffer Sales Value by Region (%), (2019-2030)
5.2 Global Bio Pharma Buffer Sales Volume by Region
5.2.1 Global Bio Pharma Buffer Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Bio Pharma Buffer Sales Volume by Region (2019-2024)
5.2.3 Global Bio Pharma Buffer Sales Volume by Region (2025-2030)
5.2.4 Global Bio Pharma Buffer Sales Volume by Region (%), (2019-2030)
5.3 Global Bio Pharma Buffer Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Bio Pharma Buffer Sales Value, 2019-2030
5.4.2 North America Bio Pharma Buffer Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Bio Pharma Buffer Sales Value, 2019-2030
5.5.2 Europe Bio Pharma Buffer Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Bio Pharma Buffer Sales Value, 2019-2030
5.6.2 Asia Pacific Bio Pharma Buffer Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Bio Pharma Buffer Sales Value, 2019-2030
5.7.2 South America Bio Pharma Buffer Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Bio Pharma Buffer Sales Value, 2019-2030
5.8.2 Middle East & Africa Bio Pharma Buffer Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Bio Pharma Buffer Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Bio Pharma Buffer Sales Value
6.2.1 Key Countries/Regions Bio Pharma Buffer Sales Value, 2019-2030
6.2.2 Key Countries/Regions Bio Pharma Buffer Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Bio Pharma Buffer Sales Value, 2019-2030
6.3.2 United States Bio Pharma Buffer Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Bio Pharma Buffer Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Bio Pharma Buffer Sales Value, 2019-2030
6.4.2 Europe Bio Pharma Buffer Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Bio Pharma Buffer Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Bio Pharma Buffer Sales Value, 2019-2030
6.5.2 China Bio Pharma Buffer Sales Value by Type (%), 2023 VS 2030
6.5.3 China Bio Pharma Buffer Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Bio Pharma Buffer Sales Value, 2019-2030
6.6.2 Japan Bio Pharma Buffer Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Bio Pharma Buffer Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Bio Pharma Buffer Sales Value, 2019-2030
6.7.2 South Korea Bio Pharma Buffer Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Bio Pharma Buffer Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Bio Pharma Buffer Sales Value, 2019-2030
6.8.2 Southeast Asia Bio Pharma Buffer Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Bio Pharma Buffer Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Bio Pharma Buffer Sales Value, 2019-2030
6.9.2 India Bio Pharma Buffer Sales Value by Type (%), 2023 VS 2030
6.9.3 India Bio Pharma Buffer Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Avantor
7.1.1 Avantor Company Information
7.1.2 Avantor Introduction and Business Overview
7.1.3 Avantor Bio Pharma Buffer Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Avantor Bio Pharma Buffer Product Offerings
7.1.5 Avantor Recent Development
7.2 Alfa Aesar (Thermo Fisher)
7.2.1 Alfa Aesar (Thermo Fisher) Company Information
7.2.2 Alfa Aesar (Thermo Fisher) Introduction and Business Overview
7.2.3 Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Product Offerings
7.2.5 Alfa Aesar (Thermo Fisher) Recent Development
7.3 Merck
7.3.1 Merck Company Information
7.3.2 Merck Introduction and Business Overview
7.3.3 Merck Bio Pharma Buffer Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Merck Bio Pharma Buffer Product Offerings
7.3.5 Merck Recent Development
7.4 Lonza
7.4.1 Lonza Company Information
7.4.2 Lonza Introduction and Business Overview
7.4.3 Lonza Bio Pharma Buffer Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Lonza Bio Pharma Buffer Product Offerings
7.4.5 Lonza Recent Development
7.5 Bio-Rad
7.5.1 Bio-Rad Company Information
7.5.2 Bio-Rad Introduction and Business Overview
7.5.3 Bio-Rad Bio Pharma Buffer Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Bio-Rad Bio Pharma Buffer Product Offerings
7.5.5 Bio-Rad Recent Development
7.6 BD
7.6.1 BD Company Information
7.6.2 BD Introduction and Business Overview
7.6.3 BD Bio Pharma Buffer Sales, Revenue and Gross Margin (2019-2024)
7.6.4 BD Bio Pharma Buffer Product Offerings
7.6.5 BD Recent Development
7.7 GE Healthcare
7.7.1 GE Healthcare Company Information
7.7.2 GE Healthcare Introduction and Business Overview
7.7.3 GE Healthcare Bio Pharma Buffer Sales, Revenue and Gross Margin (2019-2024)
7.7.4 GE Healthcare Bio Pharma Buffer Product Offerings
7.7.5 GE Healthcare Recent Development
7.8 Promega Corporation
7.8.1 Promega Corporation Company Information
7.8.2 Promega Corporation Introduction and Business Overview
7.8.3 Promega Corporation Bio Pharma Buffer Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Promega Corporation Bio Pharma Buffer Product Offerings
7.8.5 Promega Corporation Recent Development
7.9 Hamilton Company
7.9.1 Hamilton Company Company Information
7.9.2 Hamilton Company Introduction and Business Overview
7.9.3 Hamilton Company Bio Pharma Buffer Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Hamilton Company Bio Pharma Buffer Product Offerings
7.9.5 Hamilton Company Recent Development
7.10 XZL BIO-TECHNOLOGY
7.10.1 XZL BIO-TECHNOLOGY Company Information
7.10.2 XZL BIO-TECHNOLOGY Introduction and Business Overview
7.10.3 XZL BIO-TECHNOLOGY Bio Pharma Buffer Sales, Revenue and Gross Margin (2019-2024)
7.10.4 XZL BIO-TECHNOLOGY Bio Pharma Buffer Product Offerings
7.10.5 XZL BIO-TECHNOLOGY Recent Development
7.11 SRL
7.11.1 SRL Company Information
7.11.2 SRL Introduction and Business Overview
7.11.3 SRL Bio Pharma Buffer Sales, Revenue and Gross Margin (2019-2024)
7.11.4 SRL Bio Pharma Buffer Product Offerings
7.11.5 SRL Recent Development
8 Industry Chain Analysis
8.1 Bio Pharma Buffer Industrial Chain
8.2 Bio Pharma Buffer Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Bio Pharma Buffer Sales Model
8.5.2 Sales Channel
8.5.3 Bio Pharma Buffer Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of TablesList of Tables
Table 1. Bio Pharma Buffer Market Trends
Table 2. Bio Pharma Buffer Market Drivers & Opportunity
Table 3. Bio Pharma Buffer Market Challenges
Table 4. Bio Pharma Buffer Market Restraints
Table 5. Global Bio Pharma Buffer Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Bio Pharma Buffer Revenue Market Share by Company (2019-2024)
Table 7. Global Bio Pharma Buffer Sales Volume by Company (2019-2024) & (K Liter)
Table 8. Global Bio Pharma Buffer Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Bio Pharma Buffer Price by Company (2019-2024) & (USD/Liter)
Table 10. Key Manufacturers Bio Pharma Buffer Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Bio Pharma Buffer Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Bio Pharma Buffer
Table 13. Global Bio Pharma Buffer Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bio Pharma Buffer as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Bio Pharma Buffer Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Bio Pharma Buffer Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Bio Pharma Buffer Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Bio Pharma Buffer Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Bio Pharma Buffer Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Bio Pharma Buffer Sales Volume by Type: 2019 VS 2023 VS 2030 (K Liter)
Table 22. Global Bio Pharma Buffer Sales Volume by Type (2019-2024) & (K Liter)
Table 23. Global Bio Pharma Buffer Sales Volume by Type (2025-2030) & (K Liter)
Table 24. Global Bio Pharma Buffer Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Bio Pharma Buffer Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Bio Pharma Buffer Price by Type (2019-2024) & (USD/Liter)
Table 27. Global Bio Pharma Buffer Price by Type (2025-2030) & (USD/Liter)
Table 28. Global Bio Pharma Buffer Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Bio Pharma Buffer Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Bio Pharma Buffer Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Bio Pharma Buffer Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Bio Pharma Buffer Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Bio Pharma Buffer Sales Volume by Application: 2019 VS 2023 VS 2030 (K Liter)
Table 34. Global Bio Pharma Buffer Sales Volume by Application (2019-2024) & (K Liter)
Table 35. Global Bio Pharma Buffer Sales Volume by Application (2025-2030) & (K Liter)
Table 36. Global Bio Pharma Buffer Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Bio Pharma Buffer Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Bio Pharma Buffer Price by Application (2019-2024) & (USD/Liter)
Table 39. Global Bio Pharma Buffer Price by Application (2025-2030) & (USD/Liter)
Table 40. Global Bio Pharma Buffer Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Bio Pharma Buffer Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Bio Pharma Buffer Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Bio Pharma Buffer Sales Value by Region (2019-2024) & (%)
Table 44. Global Bio Pharma Buffer Sales Value by Region (2025-2030) & (%)
Table 45. Global Bio Pharma Buffer Sales Volume by Region (K Liter): 2019 VS 2023 VS 2030
Table 46. Global Bio Pharma Buffer Sales Volume by Region (2019-2024) & (K Liter)
Table 47. Global Bio Pharma Buffer Sales Volume by Region (2025-2030) & (K Liter)
Table 48. Global Bio Pharma Buffer Sales Volume by Region (2019-2024) & (%)
Table 49. Global Bio Pharma Buffer Sales Volume by Region (2025-2030) & (%)
Table 50. Global Bio Pharma Buffer Average Price by Region (2019-2024) & (USD/Liter)
Table 51. Global Bio Pharma Buffer Average Price by Region (2025-2030) & (USD/Liter)
Table 52. Key Countries/Regions Bio Pharma Buffer Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Bio Pharma Buffer Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Bio Pharma Buffer Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Bio Pharma Buffer Sales Volume, (2019-2024) & (K Liter)
Table 56. Key Countries/Regions Bio Pharma Buffer Sales Volume, (2025-2030) & (K Liter)
Table 57. Avantor Company Information
Table 58. Avantor Introduction and Business Overview
Table 59. Avantor Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2019-2024)
Table 60. Avantor Bio Pharma Buffer Product Offerings
Table 61. Avantor Recent Development
Table 62. Alfa Aesar (Thermo Fisher) Company Information
Table 63. Alfa Aesar (Thermo Fisher) Introduction and Business Overview
Table 64. Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2019-2024)
Table 65. Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Product Offerings
Table 66. Alfa Aesar (Thermo Fisher) Recent Development
Table 67. Merck Company Information
Table 68. Merck Introduction and Business Overview
Table 69. Merck Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2019-2024)
Table 70. Merck Bio Pharma Buffer Product Offerings
Table 71. Merck Recent Development
Table 72. Lonza Company Information
Table 73. Lonza Introduction and Business Overview
Table 74. Lonza Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2019-2024)
Table 75. Lonza Bio Pharma Buffer Product Offerings
Table 76. Lonza Recent Development
Table 77. Bio-Rad Company Information
Table 78. Bio-Rad Introduction and Business Overview
Table 79. Bio-Rad Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2019-2024)
Table 80. Bio-Rad Bio Pharma Buffer Product Offerings
Table 81. Bio-Rad Recent Development
Table 82. BD Company Information
Table 83. BD Introduction and Business Overview
Table 84. BD Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2019-2024)
Table 85. BD Bio Pharma Buffer Product Offerings
Table 86. BD Recent Development
Table 87. GE Healthcare Company Information
Table 88. GE Healthcare Introduction and Business Overview
Table 89. GE Healthcare Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2019-2024)
Table 90. GE Healthcare Bio Pharma Buffer Product Offerings
Table 91. GE Healthcare Recent Development
Table 92. Promega Corporation Company Information
Table 93. Promega Corporation Introduction and Business Overview
Table 94. Promega Corporation Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2019-2024)
Table 95. Promega Corporation Bio Pharma Buffer Product Offerings
Table 96. Promega Corporation Recent Development
Table 97. Hamilton Company Company Information
Table 98. Hamilton Company Introduction and Business Overview
Table 99. Hamilton Company Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2019-2024)
Table 100. Hamilton Company Bio Pharma Buffer Product Offerings
Table 101. Hamilton Company Recent Development
Table 102. XZL BIO-TECHNOLOGY Company Information
Table 103. XZL BIO-TECHNOLOGY Introduction and Business Overview
Table 104. XZL BIO-TECHNOLOGY Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2019-2024)
Table 105. XZL BIO-TECHNOLOGY Bio Pharma Buffer Product Offerings
Table 106. XZL BIO-TECHNOLOGY Recent Development
Table 107. SRL Company Information
Table 108. SRL Introduction and Business Overview
Table 109. SRL Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2019-2024)
Table 110. SRL Bio Pharma Buffer Product Offerings
Table 111. SRL Recent Development
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Bio Pharma Buffer Downstream Customers
Table 115. Bio Pharma Buffer Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Bio Pharma Buffer Product Picture
Figure 2. Global Bio Pharma Buffer Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Bio Pharma Buffer Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Bio Pharma Buffer Sales Volume (2019-2030) & (K Liter)
Figure 5. Global Bio Pharma Buffer Sales Price (2019-2030) & (USD/Liter)
Figure 6. Bio Pharma Buffer Report Years Considered
Figure 7. Global Bio Pharma Buffer Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Bio Pharma Buffer Players Sales Volume Ranking (2023) & (K Liter)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Bio Pharma Buffer Revenue in 2023
Figure 10. Bio Pharma Buffer Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Phosphates Type Picture
Figure 12. Acetates Type Picture
Figure 13. TRIS Type Picture
Figure 14. Others Picture
Figure 15. Global Bio Pharma Buffer Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Bio Pharma Buffer Sales Value Market Share by Type, 2023 & 2030
Figure 17. Global Bio Pharma Buffer Sales Volume by Type (2019 VS 2023 VS 2030) & (K Liter)
Figure 18. Global Bio Pharma Buffer Sales Volume Market Share by Type, 2023 & 2030
Figure 19. Global Bio Pharma Buffer Price by Type (2019-2030) & (USD/Liter)
Figure 20. Product Picture of Research Institution
Figure 21. Product Picture of Pharmaceutical Industry
Figure 22. Product Picture of Others
Figure 23. Global Bio Pharma Buffer Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 24. Global Bio Pharma Buffer Sales Value Market Share by Application, 2023 & 2030
Figure 25. Global Bio Pharma Buffer Sales Volume by Application (2019 VS 2023 VS 2030) & (K Liter)
Figure 26. Global Bio Pharma Buffer Sales Volume Market Share by Application, 2023 & 2030
Figure 27. Global Bio Pharma Buffer Price by Application (2019-2030) & (USD/Liter)
Figure 28. North America Bio Pharma Buffer Sales Value (2019-2030) & (US$ Million)
Figure 29. North America Bio Pharma Buffer Sales Value by Country (%), 2023 VS 2030
Figure 30. Europe Bio Pharma Buffer Sales Value (2019-2030) & (US$ Million)
Figure 31. Europe Bio Pharma Buffer Sales Value by Country (%), 2023 VS 2030
Figure 32. Asia Pacific Bio Pharma Buffer Sales Value (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Bio Pharma Buffer Sales Value by Country (%), 2023 VS 2030
Figure 34. South America Bio Pharma Buffer Sales Value (2019-2030) & (US$ Million)
Figure 35. South America Bio Pharma Buffer Sales Value by Country (%), 2023 VS 2030
Figure 36. Middle East & Africa Bio Pharma Buffer Sales Value (2019-2030) & (US$ Million)
Figure 37. Middle East & Africa Bio Pharma Buffer Sales Value by Country (%), 2023 VS 2030
Figure 38. Key Countries/Regions Bio Pharma Buffer Sales Value (%), (2019-2030)
Figure 39. Key Countries/Regions Bio Pharma Buffer Sales Volume (%), (2019-2030)
Figure 40. United States Bio Pharma Buffer Sales Value, (2019-2030) & (US$ Million)
Figure 41. United States Bio Pharma Buffer Sales Value by Type (%), 2023 VS 2030
Figure 42. United States Bio Pharma Buffer Sales Value by Application (%), 2023 VS 2030
Figure 43. Europe Bio Pharma Buffer Sales Value, (2019-2030) & (US$ Million)
Figure 44. Europe Bio Pharma Buffer Sales Value by Type (%), 2023 VS 2030
Figure 45. Europe Bio Pharma Buffer Sales Value by Application (%), 2023 VS 2030
Figure 46. China Bio Pharma Buffer Sales Value, (2019-2030) & (US$ Million)
Figure 47. China Bio Pharma Buffer Sales Value by Type (%), 2023 VS 2030
Figure 48. China Bio Pharma Buffer Sales Value by Application (%), 2023 VS 2030
Figure 49. Japan Bio Pharma Buffer Sales Value, (2019-2030) & (US$ Million)
Figure 50. Japan Bio Pharma Buffer Sales Value by Type (%), 2023 VS 2030
Figure 51. Japan Bio Pharma Buffer Sales Value by Application (%), 2023 VS 2030
Figure 52. South Korea Bio Pharma Buffer Sales Value, (2019-2030) & (US$ Million)
Figure 53. South Korea Bio Pharma Buffer Sales Value by Type (%), 2023 VS 2030
Figure 54. South Korea Bio Pharma Buffer Sales Value by Application (%), 2023 VS 2030
Figure 55. Southeast Asia Bio Pharma Buffer Sales Value, (2019-2030) & (US$ Million)
Figure 56. Southeast Asia Bio Pharma Buffer Sales Value by Type (%), 2023 VS 2030
Figure 57. Southeast Asia Bio Pharma Buffer Sales Value by Application (%), 2023 VS 2030
Figure 58. India Bio Pharma Buffer Sales Value, (2019-2030) & (US$ Million)
Figure 59. India Bio Pharma Buffer Sales Value by Type (%), 2023 VS 2030
Figure 60. India Bio Pharma Buffer Sales Value by Application (%), 2023 VS 2030
Figure 61. Bio Pharma Buffer Industrial Chain
Figure 62. Bio Pharma Buffer Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
